影响低促性腺激素型非梗阻性无精子症患者显微取精成功率的临床因素
该队列研究纳入2014至2021年间616例低促性腺激素型非梗阻性无精子症患者,探讨显微取精成功的影响因素。总体成功率为56.6%,基线促卵泡激素水平、取精前激素刺激、临床型精索静脉曲张、精索静脉结扎术史及睾丸组织病理学为独立预测因素。取精前激素刺激对正常促性腺激素患者获益更大。
要点
- 总体显微取精成功率为56.6%。
- 基线促卵泡激素、取精前激素刺激、临床型精索静脉曲张、精索静脉结扎术史及睾丸组织病理学为独立预测因素。
- 取精前激素刺激对正常促性腺激素患者获益大于高促性腺激素患者。
核心结论
- 本研究强调低促性腺激素型非梗阻性无精子症患者临床因素与显微取精成功之间的关联。
- 虽然未确立因果关系,但作者认为这些患者可能从取精前干预中获益,特别是激素刺激和精索静脉曲张修复。
研究设计与样本
- 队列研究,纳入2014至2021年间616例连续的非梗阻性无精子症且低促性腺激素(总睾酮<350 ng/dL)患者,所有患者无既往取精史。
- 患者年龄23-55岁,接受全面的临床、实验室和組織病理学诊断评估,并根据取精前是否接受激素刺激分为两个队列。
主要发现
- 总体显微取精成功率为56.6%。
- 基线促卵泡激素水平(aOR 0.97;95%CI 0.94-0.99)、取精前激素刺激(aOR 2.54;95%CI 1.64-3.93)、临床型精索静脉曲张(aOR 0.05;95%CI 0.01-0.51)、既往精索静脉结扎术史(aOR 2.55;95%CI 1.26-5.16)及睾丸组织病理学为取精成功的独立预测因素。
- 在激素预处理患者中,显微取精前睾酮水平和Δ睾酮(睾酮较基线的绝对增加值)与取精成功相关。
- 显微取精前睾酮水平418.5 ng/dL(曲线下面积0.78)和Δ睾酮258 ng/dL(曲线下面积0.76)可区分取精阳性与阴性患者。
- 亚组分析显示,取精前激素刺激对正常促性腺激素患者的获益大于高促性腺激素患者。
临床怎么用
- 作者认为低促性腺激素型非梗阻性无精子症患者可能从取精前干预中获益,特别是激素刺激和精索静脉曲张修复。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore factors influencing microdissection testicular sperm extraction (micro-TESE) success in hypogonadal men with nonobstructive azoospermia (NOA). DESIGN: A cohort study. SETTING: University-affiliated male reproductive health center. PATIENT(S): A total of 616 consecutive patients with NOA and hypogonadism (total testosterone [T] levels <350 ng/dL) underwent micro-TESE between 2014 and 2021. All patients had no prior sperm retrieval (SR) history. INTERVENTION(S): Patients aged 23-55 years underwent comprehensive clinical, laboratory, and histopathological diagnostic evaluation for NOA and were further categorized into two cohorts on the basis of pre-SR hormonal stimulation. MAIN OUTCOME MEASURE(S): A multivariable logistic regression analysis explored the associations between patient variables and micro-TESE success, defined as the presence of viable spermatozoa in extracted specimens. Adjusted odds ratios (aORs) and 95% confidence intervals (CIs) were computed to assess the relationship between SR success and relevant predictors. Sperm retrieval rates were compared between patients receiving or not hormonal stimulation, and logistic regression analysis evaluated the effect of baseline follicle-stimulating hormone levels (i.e., normogonadotropic vs. hypergonadotropic classes) on SR success. RESULT(S): The overall micro-TESE success rate was 56.6%. Baseline follicle-stimulating hormone levels (aOR, 0.97; 95% CI, 0.94-0.99), pre-SR hormonal stimulation (aOR, 2.54; 95% CI, 1.64-3.93), presence of clinical varicocele (aOR, 0.05; 95% CI, 0.01-0.51), history of previous varicocelectomy (aOR, 2.55; 95% CI, 1.26-5.16), and testicular histopathology were independent predictors of SR success. Among hormone-pretreated patients, pre-micro-TESE T levels and delta T (an absolute increase in T levels from baseline) were associated with SR success. A pre-micro-TESE T level of 418.5 ng/dL (area under the curve value: 0.78) and a delta T of 258 ng/dL (area under the value: 0.76) distinguished patients with positive and negative SR outcomes. Subgroup analysis showed that pre-SR hormonal stimulation yielded a greater benefit for normogonadotropic patients than for those who were hypergonadotropic. CONCLUSION(S): This study underscores the association between clinical factors and micro-TESE success in hypogonadal men with NOA. Although causality is not established, our findings suggest that these patients may benefit from pre-SR interventions, particularly hormonal stimulation and varicocele repair. CLINICAL TRIAL REGISTRATION NUMBER: NCT05110391.
引用
- Esteves SC, Achermann APP, Miyaoka R, et al. Clinical factors impacting microdissection testicular sperm extraction success in hypogonadal men with nonobstructive azoospermia. Fertil Steril. 2024. PMID: 38909671. doi:10.1016/j.fertnstert.2024.06.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。